Literature DB >> 25043308

PAX genes in childhood oncogenesis: developmental biology gone awry?

P Mahajan1, P J Leavey1, R L Galindo2.   

Abstract

Childhood solid tumors often arise from embryonal-like cells, which are distinct from the epithelial cancers observed in adults, and etiologically can be considered as 'developmental patterning gone awry'. Paired-box (PAX) genes encode a family of evolutionarily conserved transcription factors that are important regulators of cell lineage specification, migration and tissue patterning. PAX loss-of-function mutations are well known to cause potent developmental phenotypes in animal models and underlie genetic disease in humans, whereas dysregulation and/or genetic modification of PAX genes have been shown to function as critical triggers for human tumorigenesis. Consequently, exploring PAX-related pathobiology generates insights into both normal developmental biology and key molecular mechanisms that underlie pediatric cancer, which are the topics of this review.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25043308     DOI: 10.1038/onc.2014.209

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

Review 1.  Genomics of adult and pediatric solid tumors.

Authors:  Zahraa Rahal; Farah Abdulhai; Humam Kadara; Raya Saab
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 2.  Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Authors:  Alejandra Sanjuan-Pla; Clara Bueno; Cristina Prieto; Pamela Acha; Ronald W Stam; Rolf Marschalek; Pablo Menéndez
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

3.  Pax2 and Pax8 Proteins Regulate Urea Transporters and Aquaporins to Control Urine Concentration in the Adult Kidney.

Authors:  Ann M Laszczyk; Atsuko Y Higashi; Sanjeevkumar R Patel; Craig N Johnson; Abdul Soofi; Saji Abraham; Gregory R Dressler
Journal:  J Am Soc Nephrol       Date:  2020-05-07       Impact factor: 10.121

Review 4.  PAX9 in Cancer Development.

Authors:  Xiaoxin Chen; Yahui Li; Chorlada Paiboonrungruang; Yong Li; Heiko Peters; Ralf Kist; Zhaohui Xiong
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

5.  PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.

Authors:  Jason A Hanna; Matthew R Garcia; Alicia Lardennois; Patrick J Leavey; Dino Maglic; Alexandre Fagnan; Jonathan C Go; Jordan Roach; Yong-Dong Wang; David Finkelstein; Mark E Hatley
Journal:  Oncogene       Date:  2018-01-25       Impact factor: 9.867

6.  A rapid one-generation genetic screen in a Drosophila model to capture rhabdomyosarcoma effectors and therapeutic targets.

Authors:  Kathleen A Galindo; Tiana R Endicott; Usha Avirneni-Vadlamudi; Rene L Galindo
Journal:  G3 (Bethesda)       Date:  2014-12-09       Impact factor: 3.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.